Characterizing gaps in the preventive pharmacologic treatment of migraine: Multi‐country results from the CaMEO‐I study

Ähnliche Einträge

• Prevalence and burden of migraine in the United States: A systematic review
  von: Fred Cohen, et al.
  Veröffentlicht: (2024)
• What a long strange trip it's been: Reflections on serial snapshots of migraine prevalence and burden in the United States
  von: Fred Cohen, et al.
  Veröffentlicht: (2025)
• Challenges and opportunities for estimating and assessing migraine prevalence, incidence and impact across study populations and methodologies: Bridging global and United States findings
  von: Fred Cohen, et al.
  Veröffentlicht: (2024)
• Rates and healthcare resource utilization for people with branded acute and preventive migraine prescription medication order payer denials: An open, multi‐source dataset, observational cohort study
  von: Dawn C. Buse, et al.
  Veröffentlicht: (2026)
• Effectiveness of galcanezumab versus topiramate, amitriptyline, and other select traditional oral migraine preventives with evidence of efficacy: 3‐Month results from the TRIUMPH study
  von: Shivang Joshi, et al.
  Veröffentlicht: (2026)